OpenEMR up to 8.4.x Report/Portal/Transaction/Immunization sql injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.0 | $0-$5k | 0.00+ |
Summary
A vulnerability identified as critical has been detected in OpenEMR up to 8.4.x. Affected by this vulnerability is an unknown functionality of the component Report/Portal/Transaction/Immunization. The manipulation leads to sql injection. This vulnerability is referenced as CVE-2026-126455. Remote exploitation of the attack is possible. No exploit is available. You should upgrade the affected component.
Details
A vulnerability was found in OpenEMR up to 8.4.x and classified as critical. This issue affects some unknown functionality of the component Report/Portal/Transaction/Immunization. The manipulation with an unknown input leads to a sql injection vulnerability. Using CWE to declare the problem leads to CWE-89. The product constructs all or part of an SQL command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended SQL command when it is sent to a downstream component. Without sufficient removal or quoting of SQL syntax in user-controllable inputs, the generated SQL query can cause those inputs to be interpreted as SQL instead of ordinary user data. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
OpenEMR before 8.5.0 contains multiple missing authorization and SQL injection defects across report, portal, transaction, and immunization components. Low-privileged Front Office clerks can chain these to read arbitrary database tables including users_secure hashes, hijack patient portal identities, and forge approved clinical records.
The advisory is shared at github.com. The identification of this vulnerability is CVE-2026-126455 since 11/10/2026. The exploitation is known to be easy. The attack may be initiated remotely. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1505 for this issue.
Upgrading to version 8.5.0 eliminates this vulnerability.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Name
Version
License
Website
- Product: https://github.com/openemr/openemr/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 7.2VulDB Meta Temp Score: 7.0
VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 8.1
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Sql injectionCWE: CWE-89 / CWE-74 / CWE-707
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: OpenEMR 8.5.0
Timeline
11/10/2026 CVE reserved11/13/2026 Advisory disclosed
11/13/2026 VulDB entry created
11/13/2026 VulDB entry last update
Sources
Product: github.comAdvisory: github.com
Status: Confirmed
CNA: VulnCheck
CVE: CVE-2026-126455 (🔒)
GCVE (CVE): GCVE-0-2026-126455
GCVE (VulDB): GCVE-100-436865
Entry
Created: 11/13/2026 11:48Changes: 11/13/2026 11:48 (76)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.